FLUOCET Drug Patent Profile
✉ Email this page to a colleague
When do Fluocet patents expire, and what generic alternatives are available?
Fluocet is a drug marketed by Alpharma Us Pharms and is included in one NDA.
The generic ingredient in FLUOCET is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluocet
A generic version of FLUOCET was approved as fluocinolone acetonide by TARO on April 27th, 1982.
Summary for FLUOCET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Patent Applications: | 4,334 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FLUOCET at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for FLUOCET
US Patents and Regulatory Information for FLUOCET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpharma Us Pharms | FLUOCET | fluocinolone acetonide | CREAM;TOPICAL | 088360-001 | Jan 16, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |